Swisher SG , Roth JA, Neumanitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors C, El-Nagger AK, Fossela FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Merritt JA, Nesbitt JC, Nguyen D, Pisters KMW, Jr PJ, Schrump DS, Shin DM, Perez-Soler R, Walsh GL
What is the most appropriate strategy to monitor functional iron deficiency in the dialysed patient on rhEPO therapy
This combination creates an integrated research model that connects the hormonal trigger to the resulting cellular activity
Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules
In addition to glycemic control and weight loss, certain GLP-1 receptor agonists have FDA-approved indications to lower the risk for major adverse cardiovascular events, address moderate to severe obstructive sleep apnea, and, most recently, reduce the risk for worsening kidney disease, kidney failure, and cardiovascular death
C., Guerrero-Juarez, C
